These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2003801)

  • 1. Histologic features of human orbicularis oculi treated with botulinum A toxin.
    Harris CP; Alderson K; Nebeker J; Holds JB; Anderson RL
    Arch Ophthalmol; 1991 Mar; 109(3):393-5. PubMed ID: 2003801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated botulinum toxin injections on orbicularis oculi muscle.
    Borodic GE; Ferrante R
    J Clin Neuroophthalmol; 1992 Jun; 12(2):121-7. PubMed ID: 1385821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.
    Alderson K; Holds JB; Anderson RL
    Neurology; 1991 Nov; 41(11):1800-5. PubMed ID: 1944912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbicularis muscle pathology after botulinum toxin injection.
    Wojno T; Campbell P; Wright J
    Ophthalmic Plast Reconstr Surg; 1986; 2(2):71-4. PubMed ID: 3154544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of blepharospasm with botulinum toxin A].
    Költringer P; Haselwander H; Reisecker F
    Wien Klin Wochenschr; 1990 Jul; 102(14):403-7. PubMed ID: 2382447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial SFEMG studies of orbicularis oculi muscle after the first administration of botulinum toxin.
    Bogucki A
    Eur J Neurol; 1999 Jul; 6(4):461-7. PubMed ID: 10362900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor nerve sprouting in human orbicularis muscle after botulinum A injection.
    Holds JB; Alderson K; Fogg SG; Anderson RL
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):964-7. PubMed ID: 2335457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of blepharospasm with botulinum toxin.
    Tsoy EA; Buckley EG; Dutton JJ
    Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    Doc Ophthalmol; 1994; 86(4):395-402. PubMed ID: 7835177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of botulinum toxin in blepharospasm.
    Shorr N; Seiff SR; Kopelman J
    Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretarsal application of botulinum toxin for treatment of blepharospasm.
    Aramideh M; Ongerboer de Visser BW; Brans JW; Koelman JH; Speelman JD
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):309-11. PubMed ID: 7673963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB
    Schweiz Rundsch Med Prax; 1990 Nov; 79(48):1512-4. PubMed ID: 2255835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy.
    Borodic GE; Cozzolino D; Ferrante R; Wiegner AW; Young RR
    Ophthalmic Plast Reconstr Surg; 1991; 7(1):54-60. PubMed ID: 1708272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretarsal blepharospasm: Clinical and electromyographic characteristics.
    Grandas F; Traba A; Perez-Sanchez JR; Esteban A
    Clin Neurophysiol; 2020 Jul; 131(7):1678-1685. PubMed ID: 32280019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():40-3. PubMed ID: 1810207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54(5):206-9. PubMed ID: 1804034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in the management of blepharospasm.
    Dutton JJ; Buckley EG
    Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.